Skip to Content

IG 302 (Alfuzosin Hydrochloride Extended-Release 10 mg)

Pill with imprint IG 302 is White, Round and has been identified as Alfuzosin Hydrochloride Extended-Release 10 mg. It is supplied by Exelan Pharmaceuticals, Inc..

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 302

Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302 Front
Alfuzosin hydrochloride extended-release 10 mg IG 302 Back
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302

Alfuzosin Hydrochloride Extended-Release

Imprint
IG 302
Strength
10 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Exelan Pharmaceuticals, Inc.
Manufacturer
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
76282-0302

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.